Skip to main content
Signal8

Fisk Ryan

SEC insider (Form 3/4/5 filer). CIK 0002151480. CFO and CBO at ADARx Pharmaceuticals, Inc. (ADRX). 1 reported Form 4/5 transaction since Sep 2024; latest on Sep 24, 2026. Located in SAN DIEGO, CA.

Companies Fisk Ryan has filed insider reports for

  • ADARx Pharmaceuticals, Inc. (ADRX): Officer, CFO and CBO
Fisk Ryan profile photo

Fisk Ryan

CIK: 0002151480

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ADARx Pharmaceuticals, Inc. logo
ADRX

ADARx Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • ADARx Pharmaceuticals, Inc. logo
    ADRX

    ADARx Pharmaceuticals, Inc.

    Sep 24, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    170.7K shares-

1-1 of 1